Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057119 · ClinicalTrials.gov registry record · NA
Feasibility of SBIRT-PN
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT03057119: Completed NA study, sponsored by Florida State University.
NCT03057119 is a NA study that has completed, run by Florida State University. The registered enrollment target is 86 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03057119, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
Substance misuse is a common problem among HIV+ individuals. Research suggests that a Screening, Brief Intervention, and Treatment (SBIRT) model can be effective in reducing substance misuse in the general older adult population; however these findings have not been verified in the more vulnerable HIV+ older adult population. The present study seeks to address the problem of substance misuse in older HIV+ adults by piloting a SBIRT model for older HIV+ adults in a in a primary care setting. Individual reductions in alcohol and drug use can have significant effects on public health and safety when observed over a large population at risk for substance use problems. With wider dissemination statewide, a relatively low-cost intervention such as SBIRT could offer demonstrated benefits in this population.
Primary Outcome
To examine ratings of acceptability, the investigators will use the overall acceptability score and percentage of acceptability. Overall acceptability will be assessed by summing ratings from the 10-item questionnaire to provide a total intervention acceptability score for the intervention, such that acceptability scores for the intervention could range from 10 (low acceptability) to 50 (high acceptability). The intervention will be considered to have acceptability if 80% of the participants ran
Interventions
- BEHAVIORAL Psycho-educational content (5 Minutes)
- BEHAVIORAL Readiness Assessment (10 minutes)
- BEHAVIORAL Goal-Setting (5 minutes)
- BEHAVIORAL Identifying and prioritizing needs (5 minutes)
- BEHAVIORAL Explanation of Peer Navigator and Session wrap (5 minutes)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
What the finished NCT03057119 record still lists
NCT03057119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 5 interventions - of which Psycho-educational content (5 Minutes) is the first listed.
NCT03057119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03057119 about?
NCT03057119 is a clinical study titled "Feasibility of SBIRT-PN". Substance misuse is a common problem among HIV+ individuals. Research suggests that a Screening, Brief Intervention, and Treatment (SBIRT) model can be effective in reducing substance misuse in the general older adult population; however these findings have not been verified in the more vulnerable H...
What is the current status of trial NCT03057119?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2018-02-12. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT03057119?
The interventions under investigation include: Psycho-educational content (5 Minutes) (BEHAVIORAL), Readiness Assessment (10 minutes) (BEHAVIORAL), Goal-Setting (5 minutes) (BEHAVIORAL), Identifying and prioritizing needs (5 minutes) (BEHAVIORAL), Explanation of Peer Navigator and Session wrap (5 minutes) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03057119?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03057119's enrollment target sits among peer trials
86 976th of 2000 higher than 1,021 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI